Article
Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
Clinical lung cancer - 1 Jan 2021
Al-Ahmadi Asrar, Ardeshir-Larijani Fatemeh, Fu Pingfu, Cao Shufen, Lipka Mary Beth, Dowlati Afshin, Bruno Debora S
Abstract excerpt
BACKGROUND: Next generation sequencing (NGS) of tumor of patients with advanced non-small cell lung cancer (NSCLC) is now a standard of care that informs the clinician on the best therapeutic approach for their patients. The purpose of our study was to investigate the overall impact of NGS testing on survival as well as potential racial differences in utilization, therapeutic decision, and genomic alterations....
Read the complete abstract on PubMedTopics
- Adenocarcinoma of Lung
- Adult
- Black or African American
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
